DC Chemicals · Product datasheet

AZD5069 — Datasheet

CAT. NO. DC10773

Product page and current package options

ParameterValue
Chemical NameN-(2-((2,3-difluorobenzyl)thio)-6-(((2R,3S)-3,4-dihydroxybutan-2-yl)oxy)pyrimidin-4-yl)azetidine-1-sulfonamide
CAS No.878385-84-3
SynonymsAZD-5069; AZD 5069; AZD5069,878385-84-3
FormulaC18H22F2N4O5S2
M.Wt476.51
SMILESO=S(N1CCC1)(NC2=NC(SCC3=CC=CC(F)=C3F)=NC(O[C@H](C)[C@@H](O)CO)=C2)=O
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

AZD-5069 is a potent CXCR2 chemokine receptor antagonist, used for caner treatment.

In Vitro

AZD-5069 (Compound 2) acts as CXCR2 antagonist by inhibition of [125I]-IL-8 binding to human CXCR2 receptors and as inhibitor of GROα-induced Ca2+ flux in human neutrophils loaded with fluo-3 dye[1].

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

Target

125I-IL-8-CXCR2

References & source

[1]. Norman P. Evidence on the identity of the CXCR2 antagonist AZD-5069. Expert Opin Ther Pat. 2013 Jan;23(1):113-7.

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Cart

Request quotation